Trial Profile
Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer; the HGCSG1401 Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 Mar 2017 According to University Hospital Medical Information Network - Japan (UMIN000020861) record, the date for data entry closure is 1 Jun 2016, and the date when trial data was considered complete is 1 Sep 2016.
- 21 Jan 2017 Results of updated analysis, presented at the 2017 Gastrointestinal Cancers Symposium
- 02 Oct 2015 New trial record